A novel cancer therapeutic using thrombospondin 1 in dendritic cells - Wikidata - wikimedia - TriplyDB

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

http://www.wikidata.org/entity/Q28395685

about

Original insights on thrombospondin-1-related antireceptor strategies in cancer.Caffeic Acid Inhibits Chronic UVB-Induced Cellular Proliferation Through JAK-STAT3 Signaling in Mouse Skin.Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide.Thrombospondin-1 is a multifaceted player in tumor progression.Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8+ Immunity In Vivo.Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.

P2860

Q36221374-2948C2D2-71F1-42DE-8654-60C7CA01FF64 Q38381763-B89FEE0E-B25E-4C23-902B-4C24765EE8C6 Q41331553-C2D1E889-8A16-4CD7-B78F-A17539B8F74D Q47120215-66025C88-9475-472B-8367-27E0885B0FB1 Q47137503-669E3B81-34C5-4DDB-8AD1-C4DE0FF7D101 Q50791944-1B2ADE62-8790-4157-8A33-70123CD9F314 Q53518575-3E6C615E-160D-45EF-A93E-E74E5DD042C9

P2860

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

http://www.wikidata.org/entity/Q28395685

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@ast

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@en

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@nl

type

label

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@ast

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@en

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@nl

prefLabel

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@ast

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@en

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@nl

P1433

Q28395685-4601F152-9818-4E87-8DFC-CEED3BBECB0E

P1476

Q28395685-B85D0BDE-35A5-4116-AAE0-751527530C22

P2093

Q28395685-3088FED5-6A3F-4FA6-8A67-5EE39300C697

Q28395685-5D119C0D-5B2D-4BBA-A97A-D029E2289A63

Q28395685-781195FE-4CEE-4BE7-B214-E39F2F4BA3AC

Q28395685-9B6BECA6-E61D-4D89-824B-7D5C707D9F7E

Q28395685-9F605210-A71D-45B2-9B06-263E15F74C0C

Q28395685-A05ABF1C-B183-4A8F-B0EF-8E5030092F08

Q28395685-A4ED4C18-30EC-44A6-8DF0-970468750406

Q28395685-AA0662FA-7126-403B-A742-A2ED025A7E68

Q28395685-E7915862-402E-472E-B168-C70F2354B0E6

P2860

Q28395685-08FC220A-6329-4E75-B199-0031045E2072

Q28395685-11270EED-727F-4A9F-A0BF-AC0B32C79016

Q28395685-12814F52-D239-44FA-B82F-2098955FFCA1

Q28395685-1D3FC127-AF85-459D-87CA-3A438035E9CD

Q28395685-2008DA0B-4F96-432C-8A6D-74440F805A7E

Q28395685-233E7C00-13C1-4DA9-9568-F04001D538D0

Q28395685-24068C46-68D5-4327-9164-8A1816C56E03

Q28395685-28CD80CF-939D-4DB8-ABB7-19F15C1ECB15

Q28395685-3174A007-335E-42F5-90B0-B01080B6E6E6

Q28395685-34ECF087-07B6-47CE-B71C-BA5E8EF97840

P304

Q28395685-5CEB94B4-CB49-46C2-BF8B-986C52B053B5

P31

Q28395685-5D0641D0-5F7A-48D6-9606-2EB81EFFE5B7

P356

Q28395685-B447A1E4-C005-4AD4-9A10-7DE24CDE8431

P407

Q28395685-E0890616-066A-42DD-A90B-2247314702F5

P433

Q28395685-9E4B2912-1ADA-4996-AF68-B9FDFE9CB52E

P478

Q28395685-5A2AC550-D383-46D8-A30C-8B4F7BDDB683

P50

Q28395685-1ED5A780-9CAF-4D98-8C3B-A3E6B60139DD

P577

Q28395685-1AF60204-1299-468B-A5BE-74266C9925D8

P698

Q28395685-B729E2EB-2B9C-43D1-A1B2-EB3FF563792D

P921

Q28395685-24CF5750-E79D-4AAB-8D53-D6F89C83D352

P932

Q28395685-B32F33E2-E4C9-4BE3-99E3-5A39AFA119DA

P356

P1433

Molecular Therapy

P1476

A novel cancer therapeutic using thrombospondin 1 in dendritic cells

@en

P2093

Chi-Chen Lin

http://www.w3.org/2001/XMLSchema#string

Chih-Yang Wang

http://www.w3.org/2001/XMLSchema#string

Chiu-Mei Lin

http://www.w3.org/2001/XMLSchema#string

Jang-Yang Chang

http://www.w3.org/2001/XMLSchema#string

Ming-Derg Lai

http://www.w3.org/2001/XMLSchema#string

Shih-Shien Huang

http://www.w3.org/2001/XMLSchema#string

Tzu-Yang Weng

http://www.w3.org/2001/XMLSchema#string

Wei-Ching Chen

http://www.w3.org/2001/XMLSchema#string

Yi-Ling Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Lipid accumulation and dendritic cell dysfunction in cancer

Inhibition of cell migration by autophosphorylated mammalian sterile 20-like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-PEST

Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Regulation of immune responses by TGF-beta

P304

292-302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2013.236

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24127010

http://www.w3.org/2001/XMLSchema#string

P921

P932

3918914

http://www.w3.org/2001/XMLSchema#string